Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease

Author： Lyseng-Williamson K.A.   Plosker G.L.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.13, 2002-01, pp. : 919-942

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galantamine: A Review of its Use in Alzheimer's Disease

By Scott L.J.   Goa K.L.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1095-1122

Adis International

Access to resources Recommend Favorite

Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 193-206

Adis International

Access to resources Recommend Favorite

Rivastigmine: A Pharmacoeconomic Review of its Use in Alzheimer’s Disease

By Lamb H.M.   Goa K.L.  

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 303-318

Adis International

Access to resources Recommend Favorite

Galantamine for Alzheimer's disease

By Prvulovic David   Hampel Harald   Pantel Johannes  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine: A Review of its Use in Alzheimer's Disease

By Spencer C.M.   Noble S.  

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 391-411

Adis International

Access to resources Recommend Favorite